Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
CARDINAL HEALTH INCBullish
Cardinal Health has entered into a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. In conjunction with this renewal, the company reaffirmed its fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60 and its long-term non-GAAP EPS growth guidance of 12% to 14%.…more
CARDINAL HEALTH INC
Cardinal Health has filed its Annual Report to Security Holders (ARS) for the fiscal year ended June 30, 2026. This filing provides shareholders with a comprehensive overview of the company's annual business performance and financial condition.…more
CARDINAL HEALTH INC
Cardinal Health, Inc. has filed additional proxy soliciting materials with the SEC regarding its upcoming shareholder meeting. This filing serves as supplementary information to encourage shareholder participation and voting on key corporate proposals.…more
37 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Cardinal Health and McKesson Extend CVS Distribution Agreements Through 2032…more
Cardinal Health and McKesson have extended their pharmaceutical distribution agreements with CVS Health until 2032, securing long-term revenue stability. Both companies reaffirmed their existing fiscal 2027 earnings guidance, signaling continued operational confidence.…more
●●●●●●●● ●●●●● ●●●●●●
Cardinal Health has reaffirmed its fiscal year 2027 adjusted EPS guidance of $12.40 to $12.60. This outlook remains above the analyst consensus estimate of $12.04 per share.…more
●●●●●●●● ●●●●● ●●●●●●
Cardinal Health has signed a binding letter of intent to extend its distribution agreement with CVS Health until June 30, 2032. In conjunction with the renewal, the company reaffirmed its fiscal 2027 non-GAAP EPS growth guidance.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.